peptide 15
General Information
DRACP ID DRACP02579
Peptide Name peptide 15
Sequence XXWXXXWWX
Sequence Length 9
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
A20 | Murine B cell lymphoma | Lymphoma | IC50=67.7 ± 13.2 µM | MTT assay | 4 h | 1 |
AT84 | Murine squamous cell carcinoma | Carcinoma | IC50=154 ± 29 µM | MTT assay | 4 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity MRC-5: IC50=516 ± 5.2 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification X=Dap ((S)-2,3-diaminopropionic acid)
Chiral L
Physicochemical Information
Formula C33H20N6O-2
Absent amino acids ACDEFGHIKLMNPQRSTVY
Common amino acids X
Mass 127143
Pl 6.11
Basic residues 0
Acidic residues 0
Hydrophobic residues 3
Net charge 0
Boman Index 699
Hydrophobicity -30
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 16500
Absorbance 280nm 2062.5
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 26982623
Title Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide
Doi 10.1021/acs.jmedchem.5b02025
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_11904